With COVID-19 Risks, AllergyEasy Doctors Continue Allergy Care via Telemedicine

Much of the world has stopped for COVID-19, but not allergies. Spring trees are pollinating as prolifically as ever, creating a quandary for allergy sufferers. How do they get the medications or allergy shots they need to continue care if their doctor’s office has shut down? AllergyEasy doctors around the country are addressing this concern with a no-shots immunotherapy alternative that patients can take in the comfort of home.

AllergyEasy physicians prescribe a treatment known as sublingual immunotherapy, which works a lot like allergy shots except that it is safer and easier to comply with. Instead of allergens being injected into the skin, they are taken as liquid droplets that are dispensed under the tongue and absorbed into the bloodstream.

Over time, the body can develop immunity to these allergens (pollen, dust, mold, pet dander, etc.) When this happens, it will stop overreacting to these allergens in ways that lead to troubling symptoms.

Sublingual immunotherapy (SLIT) was developed in the 1980s after several patients developed fatal anaphylactic reactions to allergy shots. Sublingual immunotherapy provided a safer way to desensitize patients to allergens — so safe, in fact, that the drops could be taken in the comfort of home instead of under direct medical supervision at a doctor’s office (as is required with shots).

AllergyEasy provides a turnkey allergy treatment program that primary care physicians in 32 states are actively using to test allergic patients and treat them using sublingual immunotherapy. The program has weathered the recent changes due to COVID-19 seamlessly, thanks to the fact that the allergy drops can be taken at home.

“Patients don’t have to go to the doctor’s office for shots, potentially increasing their exposure to others who may have the virus,” said Dr. Stuart Agren, AllergyEasy Founder and President.

AllergyEasy physicians can order patients’ allergy drops from a compounding pharmacy for shipment directly to their homes. They can also continue office visits through telemedicine.

“Our physicians continue to see patients via phone and video,” said Dr. Agren. “This allows them to monitor patients’ progress and adjust patient prescriptions as needed to continue optimal allergy care.”

Sublingual immunotherapy has become a popular choice for people who want the convenience of home administration as well as the added safety of drops over shots. In addition, it extends the option of allergy treatment to people who might not be candidates for shots — including children who are too young to receive allergy shots, frequent travelers who can’t get to the doctor’s office regularly, and deployed military members.

Dr. Agren said that while many people fight allergies with a litany of pills (such as antihistamines) and nasal sprays, those medications do not get to the heart of the problem.

“Medications mask the symptoms of allergy, but they do nothing to address the underlying problem,” said Dr. Agren. “Immunotherapy is the only treatment capable of changing the allergy itself for lasting relief, and drops are the most convenient option for immunotherapy.”

Dr. Agren said that another advantage of the allergy drops is that they are natural and free of the side effects and contraindications of synthetic medications.

Agren has treated many thousands of sublingual immunotherapy patients in his private allergy practice since the mid-1980s. In 1995, he launched AllergyEasy in order to help primary care doctors and pediatricians around the country bring the benefits of sublingual immunotherapy to their allergic and asthmatic patients.

To learn more about AllergyEasy drops and how prescribing physicians are making the drops available to patients via telemedicine, visit www.AllergyEasy.com.

About AllergyEasy

AllergyEasy helps allergy doctors around the country provide sublingual immunotherapy (allergy drops) to their patients who suffer with allergies to pollen and food allergies (including dairy allergy, wheat allergy, nut allergy, fruit allergy and more.) AllergyEasy can connect patients to a doctor in their area who offers sublingual allergy treatment.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The information on this website or in emails is designed for educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health problems or illnesses without consulting your physician. The news site hosting this press release is not associated with AllergyEasy or Dr. Stuart Agren. It is merely re-publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.